These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7411401)

  • 1. Synthesis and biological evaluation of 2.3-diazabicyclo[2.2.1]heptane derivatives as prostaglandin endoperoxide analogs.
    Kam ST; Hanson RN; Portoghese PS
    J Pharm Sci; 1980 Sep; 69(9):1007-10. PubMed ID: 7411401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 9,11-azo-13-oxa-15-hydroxyprostanoic acid, a potent inhibitor of platelet aggregation.
    Kam ST; Portoghese PS; Gerrard JM; Dunham EW
    J Med Chem; 1979 Nov; 22(11):1402-8. PubMed ID: 533888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of garlic extracts on contractions of rat gastric fundus and human platelet aggregation.
    Gaffen JD; Tavares IA; Bennett A
    J Pharm Pharmacol; 1984 Apr; 36(4):272-4. PubMed ID: 6144781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic studies on Prostanoids. XX. Synthesis of stable (+/-)-prostaglandin H1 analogs.
    Sakai K; Inoue K; Amemiya S; Morita A; Kojima K
    Chem Pharm Bull (Tokyo); 1980 Jun; 28(6):1814-9. PubMed ID: 7408058
    [No Abstract]   [Full Text] [Related]  

  • 5. Some biological effects of prostaglandin endoperoxide analogs.
    Malmsten C
    Life Sci; 1976 Jan; 18(2):169-76. PubMed ID: 1256232
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
    Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
    Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of prostaglandin and its derivatives on the contraction of smooth muscle in rabbit aortae and platelet aggregation (author's transl)].
    Kuzuya F; Yoshimine N; Mori K; Sakamoto N
    Nihon Ronen Igakkai Zasshi; 1978 Nov; 15(6):554-61. PubMed ID: 732008
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and thromboxane A2 antagonistic activity of [[1-aryl(or benzyl)-1-(benzenesulfonamido)methyl]phenyl]alkanoic acid derivatives.
    Sakurai S; Ogawa N; Suzuki T; Kato K; Ohashi T; Yasuda S; Kato H; Ito Y
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):765-77. PubMed ID: 8681409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of precursors, products, and product analogs of prostaglandin cyclooxygenase upon iris sphincter muscle.
    Crawford CG; van Alphen GW; Cook HW; Lands WE
    Life Sci; 1978 Sep; 23(12):1255-62. PubMed ID: 101727
    [No Abstract]   [Full Text] [Related]  

  • 12. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.
    Moncada S; Gryglewski R; Bunting S; Vane JR
    Nature; 1976 Oct; 263(5579):663-5. PubMed ID: 802670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L; Fitzgerald DJ; Fitzgerald GA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.
    Crane BH; Maish TL; Maddox YT; Corey EJ; Székely I; Ramwell PW
    J Pharmacol Exp Ther; 1978 Jul; 206(1):132-8. PubMed ID: 351171
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
    Tymkewycz PM; Jones RL; Wilson NH; Marr CG
    Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoquinol selectively antagonizes contractions of rat gastric fundus to TXB2 and epoxymethano analogs of PGH2.
    Sanger GJ; Bennett A
    Adv Prostaglandin Thromboxane Res; 1980; 8():1559-60. PubMed ID: 6103666
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel prostaglandin endoperoxide mimic, prostaglandin F2alpha acetal.
    Portoghese PS; Larson DL; Abatjoglou AG
    J Med Chem; 1977 Feb; 20(2):320-1. PubMed ID: 836508
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and in vitro pharmacology of 7-oxabicyclo[2.2.1]heptane analogues of thromboxane A2/PGH2.
    Sprague PW; Heikes JE; Gougoutas JZ; Malley MF; Harris DN; Greenberg R
    J Med Chem; 1985 Nov; 28(11):1580-90. PubMed ID: 4067988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel prostaglandin endoperoxide analogs having prostacyclin-like actions on platelets from human and horse but not from rat and rabbit.
    Wilson NH; Armstrong RA; Jones RL
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():491-5. PubMed ID: 2821762
    [No Abstract]   [Full Text] [Related]  

  • 20. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
    Fitzgerald DJ; Doran J; Jackson E; FitzGerald GA
    J Clin Invest; 1986 Feb; 77(2):496-502. PubMed ID: 3003161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.